The NR2B antagonist, ifenprodil, corrects the l-DOPA-induced deficit of bilateral movement and reduces c-Fos expression in the subthalamic nucleus of hemiparkinsonian rats-Reference-Cited by-同舟云学术

The NR2B antagonist, ifenprodil, corrects the l-DOPA-induced deficit of bilateral movement and reduces c-Fos expression in the subthalamic nucleus of hemiparkinsonian rats

Published:2015-07 Issue: Volume:96 Page:45-53
ISSN:0168-0102
Container-title:Neuroscience Research
language:en
Short-container-title:Neuroscience Research

Author:

Igarashi Masakazu,Habata Toshiya^ORCID,Akita Hisanao,Noda Kazuko,Ogata Masanori,Saji Makoto^ORCID

Funder

JSPS

Publisher

Elsevier BV

Subject

General Medicine,General Neuroscience

Reference52 articles.

1. Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease;Addy;J. Clin. Pharmacol.,2009

2. Activation of the NMDA receptor involved in the alleviating after-effect of repeated stimulation of the subthalamic nucleus on motor deficits in hemiparkinsonian rats;Akita;Brain Res.,2010

3. The functional anatomy of basal ganglia disorders;Albin;Trends Neurosci.,1989

4. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease;Andersson;Neurobiol. Dis.,1999

5. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol;Bertran-Gonzalez;J. Neurosci.,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulated mGluR5 induces ER stress and DNA damage by regulating the NMDA receptor subunit NR2B;The Journal of Biochemistry;2021-12-15

2. Are ion channels potential therapeutic targets for Parkinson’s disease?;NeuroToxicology;2021-12

3. Pharmacological interactions between adenosine A2A receptor antagonists and different neurotransmitter systems;Parkinsonism & Related Disorders;2020-11

4. A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists;European Journal of Medicinal Chemistry;2020-08

5. A Review on Chronic Pain in Rheumatoid Arthritis: A Focus on Activation of NR2B Subunit of N-Methyl-D-Aspartate Receptors;Malaysian Journal of Medical Sciences;2020-02-27